icon-folder.gif   Conference Reports for NATAP  
 
  63rd Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 9-12 2012
Back grey_arrow_rt.gif
 
 
 
New treatment strategy: switching from long-term entecavir to peginterferon alfa-2a (40 kD) induces HBeAg seroconversion/HBsAg loss in patients with HBeAg-positive chronic hepatitis B (The OSST study)
 
 
  Reported by Jules Levin
AASLD Nov 9-13 2012 Boston
 
Q Ning, M Han, Y Sun, J Jiang, D Tan, J Hou, H Tang, J Sheng, M Zhao
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif

AASLD10.gif

AASLD11.gif